U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07574320) titled 'Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndrome' on April 22.
Brief Summary: Irritable bowel syndrome (IBS) tends to be a lifelong disorder and it is often frustrating to both patients and physicians. This study aim of improving symptom control, reducing healthcare burden and upgrading the quality of life of patient with diarrhea predominant IBS-D.
Patients of both sex of age group 18-65 years attending gastroenterology outpatient department Dhaka Medical College Hospital (DMCH) meeting the inclusion criteria of Diarrhea predominant irritable bowel syndrome (IBS-D) will be initially enrolled for th...